Powell, Jerry <br/><br/>
Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates.  [electronic resource] 

 -  British journal of haematology  Jan 2015 
 - 113-23 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.13109  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Chemoprevention<br/>Child<br/>Drug Substitution<br/>Factor IX--pharmacology<br/>Hemophilia B--complications<br/>Hemorrhage--etiology<br/>Humans<br/>Middle Aged<br/>Recombinant Fusion Proteins--pharmacology<br/>Treatment Outcome<br/>Young Adult